The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Latent tuberculosis infection: An overview
Open accessAbstract
Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB) disease.Individuals with LTBI represent a reservoir for active TB cases.The detection and management of LTBI is now a key component of the World Health Organization's End TB Strategy and the Government of Canada's federal framework for action on TB prevention and control.This is because people with LTBI can progress to active TB or undergo reactivation, a risk that is greatly increased in those with immunocompromising conditions.This overview provides a summary of LTBI and reactivation risk, as well as the recent advances in the diagnosis and treatment of LTBI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
Houben, R. M. G. J., & Dodd, P. J. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002152 · Cited by 2,054
Selwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,574
Jeon, C. Y., & Murray, M. B. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050152 · Cited by 1,486
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Barry, C. E., Boshoff, H. I., Dartois, V., Dick, T., Ehrt, S., Flynn, J., Schnappinger, D., Wilkinson, R. J., & Young, D. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2236 · Cited by 1,422
Uplekar, M., Weil, D., Lonnroth, K., Jaramillo, E., Lienhardt, C., Dias, H. M., Falzon, D., Floyd, K., Gargioni, G., Getahun, H., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60570-0 · Cited by 1,117
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
Sterling, T. R., Villarino, M. E., Borisov, A. S., Shang, N., Gordin, F., Bliven-Sizemore, E., Hackman, J., Hamilton, C. D., Menzies, D., Kerrigan, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104875 · Cited by 977
Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
Pai, M., Denkinger, C. M., Kik, S. V., Rangaka, M. X., Zwerling, A., Oxlade, O., Metcalfe, J. Z., Cattamanchi, A., Dowdy, D. W., Dheda, K., et al. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-13 · Cited by 886
A blood RNA signature for tuberculosis disease risk: a prospective cohort study
Zak, D. E., Penn-Nicholson, A., Scriba, T. J., Thompson, E., Suliman, S., Amon, L. M., Mahomed, H., Erasmus, M., Whatney, W., Hussey, G. D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01316-1 · Cited by 780
Towards tuberculosis elimination: an action framework for low-incidence countries
Lönnroth, K., Migliori, G. B., Abubakar, I., D'Ambrosio, L., de Vries, G., Diel, R., Douglas, P., Falzon, D., Gaudreau, M.-A., Goletti, D., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00214014 · Cited by 778
Latent Mycobacterium tuberculosis Infection
Getahun, H., Matteelli, A., Chaisson, R. E., & Raviglione, M. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1405427 · Cited by 775
THE PROGNOSIS OF A POSITIVE TUBERCULIN REACTION IN CHILDHOOD AND ADOLESCENCE
COMSTOCK, G. W., LIVESAY, V. T., & WOOLPERT, S. F. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121593 · Cited by 698
Getahun, H., Matteelli, A., Abubakar, I., Aziz, M. A., Baddeley, A., Barreira, D., Den Boon, S., Borroto Gutierrez, S. M., Bruchfeld, J., Burhan, E., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01245-2015 · Cited by 596
VYNNYCKY, E., & FINE, P. E. M. (1997) · Epidemiology and Infection · doi:10.1017/s0950268897007917 · Cited by 555
Glucocorticoid use, other associated factors, and the risk of tuberculosis
Jick, S. S., Lieberman, E. S., Rahman, M. U., & Choi, H. K. (2006) · Arthritis Care & Research · doi:10.1002/art.21705 · Cited by 477
Rehm, J., Samokhvalov, A. V., Neuman, M. G., Room, R., Parry, C., Lönnroth, K., Patra, J., Poznyak, V., & Popova, S. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-450 · Cited by 458
A consistent log-linear relationship between tuberculosis incidence and body mass index
Lonnroth, K., Williams, B. G., Cegielski, P., & Dye, C. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyp308 · Cited by 455
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
Wallis, R. S., Pai, M., Menzies, D., Doherty, T. M., Walzl, G., Perkins, M. D., & Zumla, A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60359-5 · Cited by 453
Prospects for Tuberculosis Elimination
Dye, C., Glaziou, P., Floyd, K., & Raviglione, M. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114431 · Cited by 402
Cattamanchi, A., Smith, R., Steingart, K. R., Metcalfe, J. Z., Date, A., Coleman, C., Marston, B. J., Huang, L., Hopewell, P. C., & Pai, M. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31820b07ab · Cited by 297
How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
Gw, C. (1999) · PubMed · Cited by 233
Moore, D., Liechty, C., Ekwaru, P., Were, W., Mwima, G., Solberg, P., Rutherford, G., & Mermin, J. (2007) · AIDS · doi:10.1097/qad.0b013e328013f632 · Cited by 217
Silica, silicosis and tuberculosis.
Rees, D., & Murray, J. (2007) · PubMed · Cited by 214
Tuberculosis Diagnostics in 2015: Landscape, Priorities, Needs, and Prospects
Pai, M., & Schito, M. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu803 · Cited by 193
Epidemiology of HIV-associated tuberculosis
Lawn, S. D., & Churchyard, G. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32832c7d61 · Cited by 192
Treatment of latent tuberculosis infection: An update
LOBUE, P., & MENZIES, D. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01751.x · Cited by 190
Chegou, N. N., Heyckendorf, J., Walzl, G., Lange, C., & Ruhwald, M. (2014) · European Respiratory Journal · doi:10.1183/09031936.00151413 · Cited by 163
First evaluation of QuantiFERON-TB Gold Plus performance in contact screening
Barcellini, L., Borroni, E., Brown, J., Brunetti, E., Campisi, D., Castellotti, P. F., Codecasa, L. R., Cugnata, F., Serio, C. D., Ferrarese, M., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00510-2016 · Cited by 154
Santín, M., Muñoz, L., & Comas, D. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032482 · Cited by 152
Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection
Hoff, S. T., Peter, J., Theron, G., Mellissa, P., Tingskov, P. N., Aggerbeck, H., Kolbus, D., Rühwald, M., Andersen, P. L., & Dheda, K. U. J. (2015) · European Respiratory Journal · doi:10.1183/13993003.01464-2015 · Cited by 68
Cited by
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Dartois, V. A., & Rubin, E. J. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00731-y · Cited by 490
Metadata
- Authors
- Kiazyk, S., & Ball, T.
- Venue
- Canada Communicable Disease Report
- Published
- 2017-03-02
- Volume
- 43
- Issue
- 3/4
- Pages
- 62-66
- ISSN
- 1188-4169 (ISSN-L)
- 1481-8531
- OpenAlex
- W2790324098
- Cited by
- 266
- References
- 29
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.